AKT1 and prostate cancer: It was reported that upregulation of miR-133a-3p attenuates anoikis resistance in PCa cells, whereas silencing miR-133a-3p promotes anoikis resistance and prostate cancer bone metastasis via activating PI3K/AKT signaling [51].